IL-17A通过下调SOCS1增强IL-13诱导的鼻上皮细胞eotaxin-3产生
该研究以过敏性鼻炎(AR)患者来源的人鼻上皮细胞(HNECs)为对象,体外给予IL-17A、IL-13或二者联合刺激,检测STAT6磷酸化、SOCS1蛋白及eotaxin-3表达。结果发现IL-13单独可诱导STAT6活化及eotaxin-3产生,联合IL-17A后效应进一步增强,而IL-17A单独无此作用;IL-17A可减弱IL-13诱导的SOCS1表达。结论提示IL-17A通过下调SOCS1增强IL-13驱动的STAT6活化,促进HNECs产生eotaxin-3,参与AR嗜酸性炎症。
要点
- IL-13可诱导HNECs的STAT6磷酸化、核转位及eotaxin-3产生。
- IL-17A单独对STAT6及eotaxin-3无影响,但可增强IL-13的上述效应。
- IL-17A通过减弱IL-13诱导的SOCS1表达来增强STAT6活化。
核心结论
- IL-17A通过下调SOCS1表达增强IL-13驱动的STAT6活化,进而促进HNECs产生eotaxin-3,参与AR嗜酸性炎症。
研究设计与样本
- 研究采用过敏性鼻炎患者来源的人鼻上皮细胞(HNECs)进行体外培养与刺激实验。
主要发现
- IL-13单独刺激可诱导STAT6磷酸化并促进p-STAT6核转位,导致HNECs产生eotaxin-3。
- IL-13与IL-17A联合处理进一步增强上述效应,而IL-17A单独对STAT6或eotaxin-3表达无影响。
- IL-17A或IL-13孵育均增加细胞内SOCS1蛋白水平,但加入IL-17A可减弱IL-13诱导的SOCS1表达。
临床怎么用
- 提示IL-17A与IL-13的协同作用可能放大鼻上皮嗜酸性炎症,为AR中针对IL-17A/IL-13通路的干预提供机制依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interleukin (IL)-17A is involved in the pathogenesis of allergic rhinitis (AR). Increased expression of IL-17A is correlated with disease severity and nasal eosinophilia. However, the molecular mechanisms by which IL-17A contributes to T-helper 2 cytokine IL-13-driven pathology in AR remain unclear. We sought to obtain mechanistic insight into how IL-17A and IL-13 regulate the epithelial production of eotaxin-3 representing eosinophilic inflammation in AR. METHODS: Human nasal epithelial cells (HNECs) from AR patients were cultured and stimulated with IL-17A, IL-13, or IL-17A and IL-13. Phosphorylated signal transducer activator of transcription 6 (p-STAT6) and suppressor of cytokine signaling 1 (SOCS1) in HNECs were assayed using Western blotting. Immunocytochemistry was used to determine p-STAT6-positive expression in the cells. Eotaxin-3 expression in the cells and culture supernatants was evaluated using real-time polymerase chain reaction and enzyme-linked immunosorbent assays. RESULTS: Stimulation with IL-13 alone induced STAT6 phosphorylation and promoted p-STAT6 nuclear translocation, leading to eotaxin-3 production by HNECs. These effects were further enhanced by cotreatment with IL-13 and IL-17A, whereas IL-17A alone had no impact on STAT6 or eotaxin-3 expression. Incubation with IL-17A or IL-13 increased the level of SOCS1 protein in the cells, whereas the addition of IL-17A attenuated IL-13-induced SOCS1 expression. CONCLUSION: IL-17A potentiated IL-13-driven STAT6 activation through the downregulation of SOCS1 expression, leading to enhancement of eotaxin-3 production by HNECs. These factors contributed to eosinophilic inflammation in AR.
引用
- Wang WW, Zhu K, Yu HW, et al. Interleukin-17A potentiates interleukin-13-induced eotaxin-3 production by human nasal epithelial cells from patients with allergic rhinitis. Int Forum Allergy Rhinol. 2019. PMID: 31403761. doi:10.1002/alr.22382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。